Finanzwire Finanzwire
Basculer en Français
9952 Companies
201505 Keywords
132163 Articles
107022 Press releases
Headlines Articles Press releases NLS Pharmaceutics AG Remove
  1. Home
  2. Companies
  3. NLS Pharmaceutics AG
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 08/28/2023 at 13:30, 2 years 6 months ago

    NLS Pharmaceutics CEO Issues Letter to Shareholders

    Logo of NLS Pharmaceutics AG
  • PRESS RELEASE

    published on 05/02/2023 at 14:45, 2 years 10 months ago

    NLS Pharmaceutics Receives Green Light from the U.S. FDA to Proceed with Phase 3 Clinical Program (AMAZE) for Quilience(R) (Mazindol ER) for the Treatment of Narcolepsy

    Logo of NLS Pharmaceutics AG
  • PRESS RELEASE

    published on 03/27/2023 at 14:30, 2 years 11 months ago

    NLS Pharmaceutics Announces Open Label Extension Study Six-Month Data for Quilience(R) (Mazindol ER) in the Treatment of Narcolepsy Type 1 and Type 2

    Logo of NLS Pharmaceutics AG
  • PRESS RELEASE

    published on 01/23/2023 at 14:30, 3 years 1 month ago

    NLS Pharmaceutics Announces New In-Vitro Data Reconfirming Quilience's(R) (Mazindol ER) Unique Dual Mechanism of Action Involving Significant Orexin-2 Receptor Activity

    Logo of NLS Pharmaceutics AG
  • PRESS RELEASE

    published on 01/12/2023 at 14:30, 3 years 1 month ago

    NLS Pharmaceutics Announces an R&D Update Webcast to Review the Company's Growing Portfolio of Pre-Clinical Compounds

    Logo of NLS Pharmaceutics AG
Accesswire
  • Published on 03/02/2026 at 23:50, 26 minutes ago

    Roxmore Announces Close of C$32,640,000 Non-Brokered Private Placement

  • Published on 03/02/2026 at 22:02, 2 hours 14 minutes ago

    Unusual Machines to Announce Fourth Quarter and Full-Year 2025 Financial Results and Provide Corporate Update

  • Published on 03/02/2026 at 22:00, 2 hours 16 minutes ago

    Justera Announces Definitive Agreement to Sell Port North Extracts Inc. and Resignations

  • Published on 03/02/2026 at 18:35, 5 hours 41 minutes ago

    Electrovaya Announces Results of Annual Meeting of Shareholders

  • Published on 03/02/2026 at 17:40, 6 hours 36 minutes ago

    Bioxytran, Inc. Reports Positive Phase 1b/2a Clinical Study Results for ProLectin-M, a Broad-Range Antiviral Drug in Mild to Moderate COVID-19

View all ACCESSWIRE
EQS Group
  • Published on 03/02/2026 at 22:45, 1 hour 30 minutes ago

    Huawei New-Gen OceanStor Dorado Converged All-Flash Storage Passes Enterprise Strategy Group Technical Validation

  • Published on 03/02/2026 at 21:30, 2 hours 45 minutes ago

    Huawei Launches the Xinghe Intelligent Traffic-Encryption Integration Solution to Build a Quantum-Secure Foundation for WANs

  • Published on 03/02/2026 at 21:13, 3 hours 2 minutes ago

    Voluntary tender offer for all ordinary shares of NEXT RE SIIQ S.p.A.

  • Published on 03/02/2026 at 21:00, 3 hours 15 minutes ago

    Huawei Li Peng: Accelerating Towards the Agentic Internet Era with 5G-A and AI

  • Published on 03/02/2026 at 19:50, 4 hours 25 minutes ago

    EQS-Adhoc: Beiersdorf Aktiengesellschaft: Guidance 2026 –– New Share Buyback Program

View all EQS
Les Echos
  • Published on 03/02/2026 at 18:00, 6 hours 16 minutes ago

    THERMADOR GROUPE : Annual results 2025

  • Published on 03/02/2026 at 17:35, 6 hours 41 minutes ago

    Disclosure of transactions in own shares from February 23 to February 27, 2026

  • Published on 03/02/2026 at 08:45, 15 hours 31 minutes ago

    Imerys: 2025 consolidated financial statements

  • Published on 02/27/2026 at 23:00, 3 days 1 hour ago

    Biophytis increases to €2 million the ceiling of its bond facility with Hexagon Capital Fund

  • Published on 02/27/2026 at 18:02, 3 days 6 hours ago

    AXA: Execution of a share repurchase agreement in relation to AXAs share buy-back program of up to Euro 1.25 billion

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy